Language

English

Publication Date

2-1-2022

Journal

FASEB BioAdvances

DOI

10.1096/fba.2021-00078

PMID

35141475

PMCID

PMC8814561

PubMedCentral® Posted Date

11-1-2021

PubMedCentral® Full Text Version

Post-print

Abstract

The purpose of our experiment was to explore how stochastic (inter-individual variation) gut microbiome composition may link to inflammatory bowel disease (IBD) susceptibility and guide the development of a perinatal preventative probiotic. Dextran sodium sulfate (DSS) was introduced to C57BL/BJ mice to induce acute colitis as a model of IBD. Potentially protective bacteria were identified using a discovery-validation cohort approach toward stochastic DSS susceptibility.

Keywords

: inflammatory bowel disease, Lactobacillus, microbiota, pediatric, probiotic, stochastic

Published Open-Access

yes

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.